Dermata Therapeutics

Website

Dermata Therapeutics, Inc.

7 Investors
Biotechnology
SAN DIEGO, CA

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of innovative treatments for a range of skin diseases and aesthetic conditions. By leveraging both mechanical and chemical mechanisms, Dermata aims to deliver more effective solutions for dermatologic issues, including acne, psoriasis, and rosacea.

Products & Team

Dermatology Pipeline

Dermatology treatmentsSeed

Dermata Therapeutics is developing a range of dermatology products derived from natural technologies, targeting dermatologic conditions through a combination of mechanical and chemical actions.

Value Proposition

The pipeline aims to offer more effective treatment options for common skin conditions by enhancing the body's natural responses through a dual-action approach.

Pain Points

The primary issues addressed include the need for effective, comprehensive treatments for chronic dermatologic conditions and the desire for improved aesthetic skin appearances.

Combination of mechanical and chemical mechanismsFocus on naturally derived technologiesApplicable to multiple dermatologic conditions

Gerald Proehl

Company Signatory
Chief Executive Officerat Dermata Therapeutics, Inc.
Joined Dermata Therapeutics, Inc.
January 2025
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
SAN DIEGO, CA
Primary headquarters

Funding History

Total Raised:
$5.1M
E

Equity, Option to Acquire Offering

Closed
January 2025
$2.5M
Raised
Use of Proceeds
Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3.
Progress
100%
Raised
$2.5M
Target
$2.5M
#000149315225004008
E

Equity, Option to Acquire Offering

Closed
January 2025
$2.5M
Raised
Use of Proceeds
Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3.
Progress
100%
Raised
$2.5M
Target
$2.5M
#000149315225004861